Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 595 | 343 | 0 | 0 | 0 |
| Cost of Goods | 230 | 150 | 0 | 0 | 0 |
| Gross Profit | 370 | 180 | 0 | 0 | 0 |
| Operating Expenses | 2,590 | 490 | 610 | 390 | 300 |
| Operating Income | -1,995 | -147 | -610 | -390 | -300 |
| Other Income | 1,435 | -3 | -60 | 30 | 10 |
| Pre-tax Income | -560 | -150 | -670 | -360 | -290 |
| Net Income Continuous | -300 | -50 | -675 | -369 | -288 |
| Net Income | $-300 | $-50 | $-675 | $-369 | $-288 |
| EPS Basic Total Ops | -0.40 | 0.00 | -2.00 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.41 | -0.09 | -1.20 | -0.80 | -0.40 |
| EPS Diluted Total Ops | -0.40 | 0.00 | -2.00 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.41 | -0.09 | -1.20 | -0.80 | -0.40 |
| EBITDA(a) | $-2,045 | $-97 | $-610 | $-390 | $-280 |